Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Hayley J. Sharpe, Grégoire Pau, Gerrit J.P. Dijkgraaf, et al.
Cancer Cell (2015) Vol. 27, Iss. 3, pp. 327-341
Open Access | Times Cited: 355

Showing 26-50 of 355 citing articles:

Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Ngoc Minh Nguyen, Jungsook Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1733-1733
Open Access | Times Cited: 86
Hedgehog signaling in tissue homeostasis, cancers, and targeted therapies
Junjun Jing, Zhuoxuan Wu, Jiahe Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 75
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer
James A. McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 12, pp. 2942-2976
Open Access | Times Cited: 140
An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
Christina Danial, Kavita Y. Sarin, Anthony E. Oro, et al.
Clinical Cancer Research (2015) Vol. 22, Iss. 6, pp. 1325-1329
Open Access | Times Cited: 137
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
Evan J. Lipson, Mohammed Lilo, Aleksandra Ogurtsova, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 137
Smoothened stimulation by membrane sterols drives Hedgehog pathway activity
Ishan Deshpande, Jiahao Liang, Danielle Hedeen, et al.
Nature (2019) Vol. 571, Iss. 7764, pp. 284-288
Closed Access | Times Cited: 137
Basal cell carcinoma
Michael C. Cameron, Erica Lee, Brian P. Hibler, et al.
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 2, pp. 321-339
Closed Access | Times Cited: 132
A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy
Adriana Sánchez‐Danés, Jean‐Christophe Larsimont, Mélanie Liagre, et al.
Nature (2018) Vol. 562, Iss. 7727, pp. 434-438
Open Access | Times Cited: 127
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
Sadakatsu Ikeda, Aaron M. Goodman, Philip R. Cohen, et al.
npj Genomic Medicine (2016) Vol. 1, Iss. 1
Open Access | Times Cited: 125
Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Jean Y. Tang, Mina S. Ally, Anita M. Chanana, et al.
The Lancet Oncology (2016) Vol. 17, Iss. 12, pp. 1720-1731
Closed Access | Times Cited: 124
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C. Harttrampf, Ludovic Lacroix, Marc Deloger, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 20, pp. 6101-6112
Open Access | Times Cited: 122
Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand
Xianjun Zhang, Fei Zhao, Yiran Wu, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 102
Targeting GLI factors to inhibit the Hedgehog pathway
Paola Infante, Romina Alfonsi, Bruno Botta, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 8, pp. 547-558
Open Access | Times Cited: 101
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
Jennifer K. Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 97
Hedgehog Signaling Pathway and Autophagy in Cancer
Xian Zeng, Dianwen Ju
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2279-2279
Open Access | Times Cited: 96
Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas
Ramon J. Whitson, Alex Lee, Nicole M. Urman, et al.
Nature Medicine (2018) Vol. 24, Iss. 3, pp. 271-281
Open Access | Times Cited: 95
Smoothened Regulation: A Tale of Two Signals
Angela M. Arensdorf, Suresh Marada, Stacey K. Ogden
Trends in Pharmacological Sciences (2015) Vol. 37, Iss. 1, pp. 62-72
Open Access | Times Cited: 94
Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond
Anshika Bakshi, Sandeep Chaudhary, Mehtab Rana, et al.
Molecular Carcinogenesis (2017) Vol. 56, Iss. 12, pp. 2543-2557
Open Access | Times Cited: 93
Emerging trends in the treatment of advanced basal cell carcinoma
Michael R. Migden, Anne Lynn S. Chang, Luc Dirix, et al.
Cancer Treatment Reviews (2017) Vol. 64, pp. 1-10
Open Access | Times Cited: 91
G protein–coupled receptors control the sensitivity of cells to the morphogen Sonic Hedgehog
Ganesh V. Pusapati, Jennifer H. Kong, Bhaven B. Patel, et al.
Science Signaling (2018) Vol. 11, Iss. 516
Open Access | Times Cited: 91
Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers
Masaru Katoh
Clinical Science (2019) Vol. 133, Iss. 8, pp. 953-970
Closed Access | Times Cited: 90
Roles of the Hedgehog Signaling Pathway in Epidermal and Hair Follicle Development, Homeostasis, and Cancer
Yoshinori Abe, Nobuyuki Tanaka
Journal of Developmental Biology (2017) Vol. 5, Iss. 4, pp. 12-12
Open Access | Times Cited: 88
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
Elisabeth Peer, Suzana Tesanovic, Fritz Aberger
Cancers (2019) Vol. 11, Iss. 4, pp. 538-538
Open Access | Times Cited: 85
Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis
Pingxing Xie, Philippe Lefrançois
Journal of the American Academy of Dermatology (2018) Vol. 79, Iss. 6, pp. 1089-1100.e17
Closed Access | Times Cited: 84
Primary Cilia as Signaling Hubs in Health and Disease
Yuhei Nishimura, Kousuke Kasahara, Takashi Shiromizu, et al.
Advanced Science (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 84

Scroll to top